Glycosidase Inhibition by Macrolide Antibiotics Elucidated by STD-NMR Spectroscopy

Chemistry and Biology

Volumn 15, Issue 7, 2008, Pages 739-749

  Sadeghi Khomami, Ali ^a   Lumsden, Michael D ^a   Jakeman, David L ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

CHEMBIO; MICROBIO; PROTEINS

Indexed keywords

AMINOSUGAR; ANTIINFECTIVE AGENT; DESOSAMINE; ERYTHROMYCIN; GLUCOSE; GLYCOSIDASE; MACROLIDE; METHYMYCIN;

ARTICLE; CHEMICAL MODEL; CHEMISTRY; CONFORMATION; DOSE RESPONSE; DRUG ANTAGONISM; HYDROLYSIS; IC 50; KINETICS; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PH;

AMINO SUGARS; ANTI-BACTERIAL AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ERYTHROMYCIN; GLUCOSE; GLYCOSIDE HYDROLASES; HYDROGEN-ION CONCENTRATION; HYDROLYSIS; INHIBITORY CONCENTRATION 50; KINETICS; MACROLIDES; MAGNETIC RESONANCE SPECTROSCOPY; MODELS, CHEMICAL; MOLECULAR CONFORMATION;

EID: 46849095804     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chembiol.2008.05.017     Document Type: Article

References (75)

1. 19F NMR spectroscopy. Carbohydr. Res. 327 (2000) 395-400
2. 19F NMR spectroscopy study of enzymatic transglycosylation reactions using α-D-aldohexopyranosyl fluorides as donors and acceptors. Tetrahedron Asymmetry 12 (2001) 779-783
3. Armstrong D.N., Ballantyne G.H., and Modlin I.M. Erythromycin stimulates ileal motility by activation of dihydropyridine-sensitive calcium channels. J. Surg. Res. 52 (1992) 140-146
4. Awan A., Barber J., Brennan R.J., and Parkinson J.A. Structural studies on clarithromycin (6-O-methylerythromycin A): assignments of the proton and carbon-13 NMR spectra in organic and aqueous solutions. Magn. Reson. Chem. 30 (1992) 1241-1246
5. Awan A., Brennan R.J., Regan A.C., and Barber J. Conformational analysis of the erythromycin analogs azithromycin and clarithromycin in aqueous solution and bound to bacterial ribosomes. J. Chem. Soc. Chem. Commun. 1995 (1995) 1653-1654
6. Ballardie F., Capon B., Sutherland J.D.G., Cocker D., and Sinnott M. Simple general synthesis of 2,4-dinitrophenyl glycopyranosides. J. Chem. Soc., Perkin Trans. 1 1973 (1973) 2418-2419
7. 13C NMR spectra. J. Chem. Soc., Perkin Trans. 2 1991 (1991) 1489-1494
8. Berteau O., Sandstroem C., Bielicki J., Anson D.S., and Kenne L. Glycosidase-substrate interactions analysis by STD-NMR spectroscopy: Study of α-l-fucosidase. J. Am. Chem. Soc. 125 (2003) 15296-15297
9. Bolton C.H., Foster A.B., Stacey M., and Webber J.M. Carbohydrate components of antibiotics. I. Degradation of desosamine by alkali: its absolute configuration at position 5. J. Chem. Soc. 1961 (1961) 4831-4836
10. Brecker L., Straganz G.D., Tyl C.E., Steiner W., and Nidetzky B. Saturation-transfer-difference NMR to characterize substrate binding recognition and catalysis of two broadly specific glycoside hydrolases. J. Mol. Catal., B Enzym. 42 (2006) 85-89
11. Burlingham B.T., and Widlanski T.S. An intuitive look at the relationship of Ki and IC50: a more general use of the Dixon plot. J. Chem. Educ. 80 (2003) 214-218
12. Coates A., Hu Y., Bax R., and Page C. The future challenges facing the development of new antimicrobial drugs. Nat. Rev. Drug Discov. 1 (2002) 895-910
13. Culic O., Erakovic V., and Parnham M.J. Anti-inflammatory effects of macrolide antibiotics. Eur. J. Pharmacol. 429 (2001) 209-229
14. Dreassi E., Corti P., Bezzini F., and Furlanetto S. High-performance liquid chromatographic assay of erythromycin from biological matrix using electrochemical or ultraviolet detection. Analyst 125 (2000) 1077-1081
15. Drone J., Feng H.-y., Tellier C., Hoffmann L., Tran V., Rabiller C., and Dion M. Thermus thermophilus glycosynthases for the efficient synthesis of galactosyl and glucosyl β-(1->3)-glycosides. Eur. J. Org. Chem. 2005 (2005) 1977-1983
16. Ducros V.M.A., Tarling C.A., Zechel D.L., Brzozowski A.M., Frandsen T.P., von Ossowski I., Schulein M., Withers S.G., and Davies G.J. Anatomy of glycosynthesis structure and kinetics of the humicola insolens Cel7B E197A and E197S glycosynthase mutants. Chem. Biol. 10 (2003) 619-628
17. Dwek R.A., Butters T.D., Platt F.M., and Zitzmann N. Targeting glycosylation as a therapeutic approach. Nat. Rev. Drug Discov. 1 (2002) 65-75
18. Erbas T., Varoglu E., Erbas B., Tastekin G., and Akalin S. Comparison of metoclopramide and erythromycin in the treatment of diabetic gastroparesis. Diabetes Care 16 (1993) 1511-1514
19. Fiese E.F., and Steffen S.H. Comparison of the acid stability of azithromycin and erythromycin A. J. Antimicrob. Chemother. 25 (1990) 39-47
20. Fu X., Albermann C., Jiang J., Liao J., Zhang C., and Thorson J.S. Antibiotic optimization via in vitro glycorandomization. Nat. Biotechnol. 21 (2003) 1467-1469
21. Giamarellos-Bourboulis E.J. Macrolides beyond the conventional antimicrobials: a class of potent immunomodulators. Int. J. Antimicrob. Agents 31 (2008) 12-20
22. Griffith B.R., Langenhan J.M., and Thorson J.S. 'Sweetening' natural products via glycorandomization. Curr. Opin. Biotechnol. 16 (2005) 622-630
23. Hancock S.M., Vaughan M.D., and Withers S.G. Engineering of glycosidases and glycosyltransferases. Curr. Opin. Chem. Biol. 10 (2006) 509-519
24. Haselhorst T., Wilson J.C., Liakatos A., Kiefel M.J., Dyason J.C., and von Itzstein M. NMR spectroscopic and molecular modeling investigations of the trans-sialidase from Trypanosoma cruzi. Glycobiology 14 (2004) 895-907
25. Hawkyard C.V., and Koerner R.J. The use of erythromycin as a gastrointestinal prokinetic agent in adult critical care: benefits versus risks. J. Antimicrob. Chemother. 59 (2007) 347-358
26. Henninger T.C. Recent progress in the field of macrolide antibiotics. Expert Opin. Ther. Pat. 13 (2003) 787-805
27. Hommalai G., Withers S.G., Chuenchor W., Cairns J.R.K., and Svasti J. Enzymatic synthesis of cello-oligosaccharides by rice BGlu1 β-glucosidase glycosynthase mutants. Glycobiology 17 (2007) 744-753
28. Honda Y., and Kitaoka M. The first glycosynthase derived from an inverting glycoside hydrolase. J. Biol. Chem. 281 (2006) 1426-1431
29. Hrmova M., and Fincher G.B. Structure-function relationships of β-D-glucan endo- and exohydrolases from higher plants. Plant Mol. Biol. 47 (2001) 73-91
30. Ianaro A., Ialenti A., Maffia P., Sautebin L., Rombola L., Carnuccio R., Iuvone T., D'Acquisto F., and Di Rosa M. Anti-inflammatory activity of macrolide antibiotics. J. Pharmacol. Exp. Ther. 292 (2000) 156-163
31. Jahn M., Stoll D., Warren R.A.J., Szabo L., Singh P., Gilbert H.J., Ducros V.M.A., Davies G.J., and Withers S.G. Expansion of the glycosynthase repertoire to produce defined manno-oligosaccharides. Chem. Commun. (Camb). 2003 (2003) 1327-1329
32. Jakeman D.L., and Withers S.G. Engineering glycosidases for constructive purposes. In: Teeri T.T., Svensson B., Gilbert H.J., and Feizi T. (Eds). Carbohydrate Bioengineering: Interdisciplinary Approaches (2002), Royal Society of Chemistry, Cambridge, UK 3-8
33. Jaret R.S., Mallams A.K., and Reimann H. Megalomicins. IV. Structures of megalomicins A, B, C1, and C2. J. Chem. Soc., Perkin Trans. 1 (1973) 1374-1388
34. Juenneman J., Lundt I., and Thiem J. Preparation of some 2-deoxy- and 2,6-dideoxy-glycosyl fluorides. Acta Chem. Scand. 45 (1991) 494-498
35. Kameda Y., Asano N., Takeuchi M., Yamaguchi T., Matsui K., Horii S., and Fukase H. Epivaliolamine and deoxyvalidamine, new pseudo-aminosugars produced by Streptomyces hygroscopicus. J. Antibiot. (Tokyo) 38 (1985) 1816-1818
36. Lazarevski G., Vinkovic M., Kobrehel G., Dokic S., Metelko B., and Vikic-Topic D. Conformational analysis of azithromycin by NMR spectroscopy and molecular modeling. Tetrahedron 49 (1993) 721-730
37. Maxwell V.L., Evinson E.L., Emmerson D.P.G., and Jenkins P.R. Synthesis, glycosidase activity and X-ray crystallography of 3-amino-sugars. Org. Biomol. Chem. 4 (2006) 2724-2732
38. Mayer M., and Meyer B. Characterization of ligand binding by saturation transfer difference NMR spectroscopy. Angew. Chem. Int. Ed. Engl. 38 (1999) 1784-1788
39. Mayer M., and Meyer B. Group epitope mapping by saturation transfer difference NMR to identify segments of a ligand in direct contact with a protein receptor. J. Am. Chem. Soc. 123 (2001) 6108-6117
40. Mendez C., and Salas J.A. Altering the glycosylation pattern of bioactive compounds. Trends Biotechnol. 19 (2001) 449-456
41. Omura S., Tsuzuki K., Sunazuka T., Toyota H., Takahashi I., and Itoh Z. Gastrointestinal motor-stimulating activity of macrolide antibiotics and the structure-activity relationship. J. Antibiot. (Tokyo) 38 (1985) 1631-1632
42. Pyetan E., Baram D., Auerbach-Nevo T., and Yonath A. Chemical parameters influencing fine-tuning in the binding of macrolide antibiotics to the ribosomal tunnel. Pure Appl. Chem. 79 (2007) 955-968
43. Quiros L.M., Hernandez C., and Salas J.A. Purification and characterization of an extracellular enzyme from Streptomyces antibioticus that converts inactive glycosylated oleandomycin into the active antibiotic. Eur. J. Biochem. 222 (1994) 129-135
44. Rao F.V., Houston D.R., Boot R.G., Aerts J.M.F.G., Hodkinson M., Adams D.J., Shiomi K., Omura S., and van Aalten D.M.F. Specificity and affinity of natural product cyclopentapeptide inhibitors against A. fumigatus, human, and bacterial chitinases. Chem. Biol. 12 (2005) 65-76
45. Rubin B. Immunomodulatory properties of macrolides: overview and historical perspective. Am. J. Med. 117 (2004) S2-S4
46. Salleh H.M., Mullegger J., Reid S.P., Chan W.Y., Hwang J., Warren R.A., and Withers S.G. Cloning and characterization of Thermotoga maritima β-glucuronidase. Carbohydr. Res. 341 (2006) 49-59
47. San Jose E., Munoz-Fernandez M.A., and Alarcon B. Megalomicin inhibits HIV-1 replication and interferes with gp160 processing. Virology 239 (1997) 303-314
48. Schlunzen F., Zarivach R., Harms J., Bashan A., Tocilj A., Albrecht R., Yonath A., and Franceschl F. Structural basis for the interaction of antibiotics with the peptidyl transferase center in eubacteria. Nature 413 (2001) 814-821
49. Sharma S.K., Corrales G., and Penades S. Single step stereoselective synthesis of unprotected 2,4-dinitrophenyl glycosides. Tetrahedron Lett. 36 (1995) 5627-5630
50. Shiono T., and Hayasaka S. Aminoglycoside antibiotics and lysosomal enzymes of human tears. Arch. Ophthalmol. 103 (1985) 1747-1749
51. Sweetman S.C. Martindale. The Complete Drug Reference. 33rd Edition (2002), Pharmaceutical Press, London
52. Takeuchi M., Kamata K., Yoshida M., Kameda Y., and Matsui K. Inhibitory effect of pseudo-aminosugars on oligosaccharide glucosidases I and II and on lysosomal α-glucosidase from rat liver. J. Biochem. (Tokyo) 108 (1990) 42-46
53. Thibodeaux C.J., and Liu H.-W. Manipulating nature's sugar biosynthetic machineries for glycodiversification of macrolides: recent advances and future prospects. Pure Appl. Chem. 79 (2007) 785-799
54. Thibodeaux C.J., Melancon C.E., and Liu H.-W. Unusual sugar biosynthesis and natural product glycodiversification. Nature 446 (2007) 1008-1016
55. Thiem J. Applications of enzymes in synthetic carbohydrate chemistry. FEMS Microbiol. Rev. 16 (1995) 193-211
56. Vaughan M.D., Johnson K., DeFrees S., Tang X., Warren R.A.J., and Withers S.G. Glycosynthase-mediated synthesis of glycosphingolipids. J. Am. Chem. Soc. 128 (2006) 6300-6301
57. Walsh C., Freel Meyers C.L., and Losey H.C. Antibiotic glycosyltransferases: antibiotic maturation and prospects for reprogramming. J. Med. Chem. 46 (2003) 3425-3436
58. Wang Q., Graham R.W., Trimbur D., Warren R.A.J., and Withers S.G. Changing enzymic reaction mechanisms by mutagenesis: Conversion of a retaining glucosidase to an inverting enzyme. J. Am. Chem. Soc. 116 (1994) 11594-11595
59. Wang L., Kitaichi K., Hui C.S., Takagi K., Takagi K., Sakai M., Yokogawa K., Miyamoto K.-I., and Hasegawa T. Reversal of anticancer drug resistance by macrolide antibiotics in vitro and in vivo. Clin. Exp. Pharmacol. Physiol. 27 (2000) 587-593
60. Wang Y.-S., Liu D., and Wyss D.F. Competition STD NMR for the detection of high-affinity ligands and NMR-based screening. Magn. Reson. Chem. 42 (2004) 485-489
61. Wen X., Yuan Y., Kuntz D.A., Rose D.R., and Pinto B.M. A combined STD-NMR/molecular modeling protocol for predicting the binding modes of the glycosidase inhibitors kifunensine and salacinol to golgi α-mannosidase II. Biochemistry 44 (2005) 6729-6737
62. White A.A., and Simon R.A. Macrolide antibiotics as anti-inflammatory agents. Curr. Allergy Asthma Rep. 5 (2005) 1-3
63. Wiley P.F. Desosamine hydrochloride. From erythromycin. In: Wolfrom M.L., BeMiller J.N., and Whistler R.L. (Eds). Methods in Carbohydrate Chemistry (1962), Academic Press, New York 257-259
64. Williams S.J., Mark B.L., Vocadlo D.J., James M.N.G., and Withers S.G. Aspartate 313 in the Streptomyces plicatus hexosaminidase plays a critical role in substrate-assisted catalysis by orienting the 2-acetamido group and stabilizing the transition state. J. Biol. Chem. 277 (2002) 40055-40065
65. Winchester B., and Fleet G.W.J. Amino-sugar glycosidase inhibitors: versatile tools for glycobiologists. Glycobiology 2 (1992) 199-210
66. Woo P.W.K., Dion H.W., Durham L., and Mosher H.S. Stereochemistry of desosamine. An N.M.R. analysis. Tetrahedron Lett. 1962 (1962) 735-739
67. Yan J., Kline A.D., Mo H., Shapiro M.J., and Zartler E.R. The effect of relaxation on the epitope mapping by saturation transfer difference NMR. J. Magn. Reson. 163 (2003) 270-276
68. Yang J., Hoffmeister D., Liu L., Fu X., and Thorson J.S. Natural product glycorandomization. Bioorg. Med. Chem. 12 (2004) 1577-1584
69. Yang M., Davies G.J., and Davies B.G. A glycosynthase catalyst for the synthesis of flavonoid glycosides. Angew. Chem. Int. Ed. Engl. 46 (2007) 3885-3888
70. Yatsunami J., Fukuno Y., Nagata M., Tominaga M., Aoki S., Tsuruta N., Kawashima M., Taniguchi S.I., and Hayashi S.-I. Antiangiogenic and antitumor effects of 14-membered ring macrolides on mouse B16 melanoma cells. Clin. Exp. Metastasis 17 (1999) 361-367
71. Yoon J.H., and Rhee J.S. The efficient enzymatic synthesis of N-acetyllactosamine in an organic co-solvent. Carbohydr. Res. 327 (2000) 377-383
72. Zalewska-Kaszubska J., and Gorska D. Anti-inflammatory capabilities of macrolides. Pharmacol. Res. 44 (2001) 451-454
73. Zhang C., Fu Q., Albermann C., Li L., and Thorson Jon S. The in vitro characterization of the erythronolide mycarosyltransferase EryBV and its utility in macrolide diversification. ChemBioChem 8 (2007) 385-390
74. Zhao L., Sherman D.H., and Liu H.-W. Biosynthesis of desosamine: Molecular evidence suggesting β-glucosylation as a self-resistance mechanism in methymycin/neomethymycin producing strain, Streptomyces venezuelae. J. Am. Chem. Soc. 120 (1998) 9374-9375
75. Zhao L., Beyer N.J., Borisova S.A., and Liu H.-W. β-Glucosylation as a part of self-resistance mechanism in mthymycin/pikromycin producing strain Streptomyces venezuelae. Biochemistry 42 (2003) 14794-14804